https://www.marketscreener.com/quote/stock/BIOXCEL-THERAPEUTICS-INC-41713826/news/BioXcel-Therapeutics-to-Host-BXCL701-Key-Opinion-Leader-Day-to-Highlight-Company-s-Investigational-42927579/
0
0
BioXcel Therapeutics to Host BXCL701 Key Opinion Leader Day to Highlight Company's Investigational, Oral Innate Immune Activator for Rare Form of Prostate Cancer - Marketscreener.com
+ 25 more
2/8/23 at 4:01am
Organization
Marketscreener.com
Author
MarketScreener
Details
52 words
Summarize
Pharmaceuticals & Biotech Business & Industrial Health Foundations & Medical Research Opinion Leader BioXcel Therapeutics BXCL701 Investigational Oral Innate Immune Activator NEW HAVEN CT
NEW HAVEN, Conn., Feb. 08, 2023 -- BioXcel Therapeutics, Inc. , a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and... | February 8, 2023
Create an account or login to join the discussion